Xueba’s medical black technology system

Chapter 113 Revenge from Johnson
The academic report in the morning was over, but the academic report agenda in the afternoon was still fully booked.

The meeting starts at 02:30 pm.

As soon as he walked into the venue, Lu Liang was about to find a seat and sit down.

"Hey!"

Lu Liang suddenly felt someone tapping him on the shoulder. Lu Liang turned around and found Ruan Shishi standing behind him.

Lu Liang glanced around and found Ruan Shishi alone. He asked curiously: "Have you mentored them?"

Ruan Shishi replied: "My instructor said that we should decide whether to listen to the report or read the poster. As long as we don't leave the venue, it will be fine."

Lu Liang had a look of surprise on his face, and then he said: "The meeting is about to start. Let's find a place to sit down first."

Ruan Shishi nodded, then picked a seat with Lu Liang and sat down.

Ruan Shishi then asked: "Student Lu, what were you doing this morning? I didn't even see you in the venue."

Lu Liang replied: "I went to read the poster."

"No wonder, have you found any interesting research?"

"I guess there is."

Lu Liang thought about the answer for a moment, and then asked: "You, what have you gained after listening to the report all morning?"

After hearing Lu Liang's question, Ruan Shishi immediately grimaced: "I didn't understand what they were talking about."

Lu Liang was speechless for a moment.

However, Ruan Shishi immediately said: "However, I still gained a lot."

"For example."

"I found that the fruits in the cafeteria are quite delicious. I ate all the fruits that I was reluctant to buy at school."

The corner of Lu Liang's mouth twitched: "That's all you can gain."

Ruan Shishi looked helpless: "Then what can I do?"

During the exchange between Lu Liang and Ruan Shishi, the afternoon meeting also began.

The first person to take the stage to report was a middle-aged man wearing glasses.

The topic reported by the man was: "Analysis and discussion of the combined use of daclatasvir hydrochloride tablets and asunaprevir soft capsules in the treatment of hepatitis C."

Lu Liang flipped through the meeting manual and was a little surprised when he saw the identity of the other party.

The unit behind this person is Remai Pharmaceuticals.

This pharmaceutical company is also considered one of the top pharmaceutical companies in the country.

But the question is, shouldn't these pharmaceutical companies be more concerned about their own interests? Why would they be interested in sending people to attend such academic conferences?
Lu Liang shook his head and was too lazy to continue thinking. Instead, he concentrated on listening to the report.

The content of the report is for the drug daclatasvir hydrochloride tablets.

This is the latest anti-hepatitis C drug from abroad. Unlike other broad-spectrum antiviral drugs, this drug mainly targets the hepatitis C virus.

Just in the middle of the report, the door of the academic lecture hall was suddenly pushed open, and a professional woman in a black formal suit hurriedly walked towards the man on the stage.

The report was suddenly interrupted, causing Lu Liang to frown.

Even the man on the stage was very dissatisfied and said to the woman: "What's wrong with you? Come here at this time, I'm still reporting!"

"Mr. Wang, Mr. Wang, something happened!"

The woman couldn't care about anything else at the moment, so she leaned into the man's ear and whispered a few words.

Although he didn't know what the woman said, Lu Liang could see that the man's expression changed drastically after listening.

The man picked up the phone and said in a panic: "I'm sorry, professors and scholars, something unexpected happened here. My report ends here. Please bear with me."

After saying that, the man put down the phone and hurriedly followed the woman.

This sudden change immediately caused an uproar in the audience, and everyone began to talk about what happened.

After all, suddenly leaving the room in the middle of a lecture has almost never happened in previous academic conferences.

Upon seeing this, the host quickly walked onto the stage to maintain order in the venue.

"What's going on?" Ruan Shishi on the side couldn't help but muttered.

"Who knows?" Lu Liang also shook his head.

Fortunately, this chaos did not last long. Just when Lu Liang was wondering, the phone in his pocket suddenly vibrated.

Lu Liang took out his cell phone and looked at it, and found that it was Ji Hong who had sent him a message.

Ji Hong asked: "Are you still at the venue now?"

Lu Liang replied: "Here, what's the matter, teacher?"

Ji Hong continued to send a message: "Come back, there is something urgent."

When he saw this news, Lu Liang was stunned?
What's going on?

Although Lu Liang was puzzled, he didn't care to ask any more questions now. He said to Ruan Shishi, "I have something urgent. Should I go back to school first?"

"Ah, you went back to school so early?"

"Ah."

After speaking, Lu Liang didn't wait for Ruan Shishi to ask the specific reason. He took his things and hurried outside.

Lu Liang went back to his room to pack his things, then booked the nearest flight ticket. After checking out, he hurried to the airport.

The flight lasted two hours, so it was still early after getting off the plane.

As soon as Lu Liang left the airport, he received a message from Ji Hong: "I'll wait for you in the parking lot."

This news made Lu Liang grin. What's going on? The instructor came to pick up his students in person?

However, this also made Lu Liang feel the seriousness of the problem. He did not dare to neglect at all and hurried towards the parking lot.

Soon, Lu Liang found Ji Hong in the airport parking lot. Ji Hong was standing next to the car.

Lu Liang walked up and said, "Teacher, what's the matter? It's so urgent?"

"Get in the car, I'll tell you in the car." Ji Hong opened the trunk of the car.

Lu Liang put his luggage in the trunk, and then followed Ji Hong into the car. As the car started slowly, Ji Hong did not drive towards the school, but turned around.

"Teacher, where are we going?"

"go to a meeting."

Ji Hong's expression was a little grim.

Lu Liang asked doubtfully: "Did something big happen?"

Ji Hong spoke slowly at this time and asked: "Xiao Lu, how much do you know about hepatitis C?"

Hepatitis C?

When asked this question,
Although Lu Liang didn't know much about hepatitis C, he had heard about it more or less.

Hepatitis C, a disease caused by the hepatitis C virus, is mainly spread through blood transfusions, acupuncture and other methods.

This virus greatly damages the physiological functions of the liver and can cause continuous inflammation to induce cirrhosis and liver cancer!
Lu Liang answered truthfully.

Ji Hong then asked: "How much do you know about the treatment drugs for hepatitis C?" "The antiviral drug ribavirin is combined with interferon for treatment." Lu Liang answered.

This is currently the most common treatment method for hepatitis C in China.

However, this method is not very effective, because this treatment method cannot completely remove the virus from the body, and there is a high probability of recurrence.

Ji Hong nodded: "Then do you know daclatasvir hydrochloride?"

Daclatasvir hydrochloride?

Lu Liang was stunned for a moment. Wasn't this the one who interrupted the topic in the middle of the report at the meeting?

Lu Liang replied: "I know, there are still related issues at the meeting."

Daclatasvir hydrochloride, also known as Bailize, is the latest anti-hepatitis C drug in foreign countries, compared with traditional antiviral drugs.

The biggest feature of Bailize is that it can completely eliminate the hepatitis virus in patients with hepatitis C.

Ji Hong took a deep breath and said: "Xiao Lu, you also know that there are a large number of hepatitis C patients in the country, so there is an urgent need for this kind of drug that can completely treat hepatitis C disease."

"Therefore, when Balize came out, the domestic Remedi Pharmaceuticals was already negotiating with the production company that produces Balize, namely Bristol-Myers Squibb."

“Not long ago, domestic Remedi Pharmaceuticals won the authorization from Bristol-Myers Squibb during negotiations, and they just had to sign the contract.”

Lu Liang frowned and asked in confusion: "Isn't this a good thing?"

With the authorization from Bristol-Myers Squibb, Remedi Pharmaceuticals will be able to produce Bilize domestically in the future, which is undoubtedly a huge good thing for many hepatitis C patients.

Ji Hong shook his head: "That's the problem. Just this morning, we just received the news that Bristol-Myers Squibb's attitude has made a 180-degree turn. It directly refused to authorize the drug patent and was unwilling to sign the contract."

"why?"

There was a look of astonishment on Lu Liang's face. It was clear that everything had been negotiated and the only thing left was to sign the contract. Why did it suddenly take a turn?

However, now Lu Liang suddenly understood why the person from Ruimai Medicine left in a hurry in the middle of his report. It was because of this incident.

Ji Hong looked at Lu Liang helplessly: "Actually, if you want to talk about it, it's mainly because of you!"

"what?"

Lu Liang was a little confused, why did this matter that he had never been able to play for eight lifetimes be related to him inexplicably.

Ji Hong said: "The news report should be out. You can find out by reading the news."

Lu Liang quickly turned on his phone and started searching on the browser for several keywords such as hepatitis C and Bai Lize.

Soon, a report appeared on Lu Liang's mobile phone screen.

The title of this report is: "Due to a certain domestic pharmaceutical company, Bristol-Myers Squibb refused to provide drug patent authorization to Remedy. 》

This report was published just an hour ago, but as of now, it has been viewed more than [-] times.

Lu Liang clicked on this report and started browsing.

"Bristol Squibb claimed that a certain domestic pharmaceutical company was not humanitarian and engaged in double-standard behavior. The drugs were priced extremely low domestically, but when they were sold out overseas, they maliciously raised the price of the drugs and did not abide by the principles of free market."

"Therefore, Bristol-Myers Squibb has temporarily refused to provide drug patent authorization to Remedy. They claimed that they will reconsider the drug pricing of Bilize in the country and may increase the drug price several times."

When Lu Liang saw this news, the corners of his mouth twitched.

Good guy, he really has something to do with it.

A certain pharmaceutical company in the news probably refers to his pharmaceutical company.

However, Lu Liang was puzzled. This matter was between him and Johnson. Why did Bristol-Myers Squibb come over to join in the fun?

Lu Liang then looked down.

"The above are remarks made by Mr. Johnson, a shareholder of Bristol-Myers Squibb, at a press conference."

Lu Liang's expression suddenly became strange.

It turned out to be Bristol-Myers Squibb's largest shareholder.

That's fine.

Lu Liang couldn't help but sigh. He now understood why the two companies had a good negotiation before and were about to sign a contract, but suddenly Bristol-Myers Squibb changed their mind.

I bet it was that guy Johnson who was in the way.

After all, he is a shareholder of Bristol-Myers Squibb, and his words still hold considerable weight within Bristol-Myers Squibb.

In a sense, this can be regarded as revenge from Johnson.

However, compared to the word revenge, Lu Liang felt that another word was more suitable.

That is pressure!
After all, Johnson shouldn't be too obvious about his ideas.

That was to arouse public opinion by refusing drug patent authorization, thus forcing Lu Liang to agree to price the drug to an extremely low level and license it to him.

Lu Liang flipped through the comments on the news, and as expected, the comment area was filled with smoke.

"Which pharmaceutical company is this? Can you do some personnel work?"

"How many people are waiting for this medicine to cure their illnesses!"

"I heard that Bristol-Myers Squibb is really doing good things this time. A course of 12 treatments with three bottles of medicine only costs more than 2 yuan. Where can I find such cheap medicine!"

"If you do this, who knows how much more expensive this medicine will be!"

Good guy, Lu Liang has finally seen the differences in this world.

More than 2 yuan is still cheap. What kind of wealthy family does this have to be?

Looking at the words in the comment area, Lu Liang's eyes twitched.

He has every reason to suspect that these people are all trolls hired by Bristol-Myers Squibb?
However, if you just want him to agree to sell the medicine at a low price, then the other party may think of the matter too simply.

Lu Liang curled his lips, put away his phone, and already had a rough response strategy in mind.

At this moment, Ji Hong had already driven to his destination.

Lu Liang was very familiar with this place, the Pharmaceutical Research Institute.

"Let's go, Xiao Lu, go to the meeting."

Ji Hong greeted Lu Liang, and after Lu Liang got out of the car, he walked towards the Institute of Drug Research.

The meeting took place in the conference room on the second floor of the Institute of Drug Research.

Lu Liang followed Ji Hong to the conference room on the second floor.

However, just as he opened the door, Lu Liang immediately felt a depressing breath coming towards his face.

In the conference room, in addition to Chen Shen, the director of the institute, there were also some faces that Lu Liang didn't recognize.

However, Lu Liang knew one of these people.

This person was Wang He from Remai Pharmaceuticals who left the room in a hurry in the middle of his presentation at the academic conference today.

As for the name Wang He, Lu Liang saw it from the conference manual, not that he had any interaction with Wang He.

After Lu Liang and Ji Hong sat down, Chen Shen, who was the host of the meeting and convened the meeting, spoke.

"Now that everyone is here, let's officially start our meeting."

(End of this chapter)